Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan

Hiroaki Saito, Akihiko Ozaki, Yasuma Kobayashi, Toyoaki Sawano, Tetsuya Tanimoto

JAMA Internal Medicine · 2019 · 38 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

more likely to have shorter drug trajectories starting after 2000, to be primary opioid analgesic users who transitioned to heroin, and to be less likely to have histories of opioid agonist treatment. The distinct age distribution and drug involvement of overdose deaths among New York City blacks, Latinos, and whites, along with complementary evidence about drug use trajectories, highlight the need for heterogeneous approaches to treatment and the equitable allocation of treatment and health care resources to reach diverse populations at risk of overdose.

References

3